Home
About
∨
Profile
Who We Are
Board of Directors
Services
∨
Overview
Licensing
Technology Sourcing
Technologies
∨
Featured Technologies
Portfolio
News & Press
∨
Current
2021
Investors
∨
CTI at a Glance
Board of Directors
Who We Are
SEC Filings
Corporate Governance
Investor Contacts
Contact
∨
Corporate Offices
Investor Contacts
Latest Press Releases
7 Oct 2015
Calmare Therapeutics Incorporated to Present at the Robins Equity Research Round-up Conference
16 Sep 2015
Calmare Therapeutics G.S.A Contract Extended Through the First Quarter of 2016
15 Sep 2015
Calmare Therapeutics Incorporated Appoints Stephen J. D'Amato, M.D., F.A.C.E.P. Chief Medical Officer
25 Jun 2015
Calmare Therapeutics Awarded GSA Contract Extension
24 Jun 2015
Calmare Therapeutics Reports Year End; Fourth quarter 2014 Results
Archives
2023
2022
2021
Add the
CTI News & Press
RSS feed to your reader.
Saturday, June 10th 2023
Terms of Service
|
Privacy
|
Legal
|
Sitemap
|
Copyright Calmare Therapeutics Incorporated © 1999-2023